A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling

Prostate

Volumn 72, Issue 16, 2012, Pages 1779-1788

  Huang, Mingguo ^a   Narita, Shintaro ^a   Numakura, Kazuyuki ^a   Tsuruta, Hiroshi ^a   Saito, Mitsuru ^a   Inoue, Takamitsu ^a   Horikawa, Yohei ^a   Tsuchiya, Norihiko ^a   Habuchi, Tomonori ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

CC chemokine receptor 2; high fat diet; monocyte chemoattractant protein 1; prostate cancer

Indexed keywords

CHEMOKINE RECEPTOR CCR2; GAMMA INTERFERON; GROWTH FACTOR; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; SMALL INTERFERING RNA; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER CELL; CANCER GROWTH; CARBOHYDRATE DIET; CELL PROLIFERATION; CONTROLLED STUDY; EX VIVO STUDY; FOOD INTAKE; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL2; CYTOKINES; DIET, HIGH-FAT; DISEASE PROGRESSION; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; NEOPLASM TRANSPLANTATION; PROSTATE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84867867016     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22531     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics. CA Cancer J Clin 2010; 60 (5): 277-300.
2. Hsing AW, Tsao L, Devesa SS,. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85 (1): 60-67.
3. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM,. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63 (6): 963-966.
4. Ambrosini GL, Fritschi L, de Klerk NH, Mackerras D, Leavy J,. Dietary patterns identified using factor analysis and prostate cancer risk: A case control study in Western Australia. Ann Epidemiol 2008; 18 (5): 364-370.
5. Alvarez-Leon EE, Roman-Vinas B, Serra-Majem L,. Dairy products and health: A review of the epidemiological evidence. Br J Nutr 2006; 96 (Suppl. 1): S94-S99.
6. Narita S, Tsuchiya N, Saito M, Inoue T, Kumazawa T, Yuasa T, Nakamura A, Habuchi T,. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis. Prostate 2008; 68 (3): 321-335.
7. Vykhovanets EV, Shankar E, Vykhovanets OV, Shukla S, Gupta S,. High-fat diet increases NF-kappaB signaling in the prostate of reporter mice. Prostate 2011; 71 (2): 147-156.
8. Zadra G, Priolo C, Patnaik A, Loda M,. New strategies in prostate cancer: Targeting lipogenic pathways and the energy sensor AMPK. Clin Cancer Res 2010; 16 (13): 3322-3328.
9. Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y, Satoh S, Habuchi T,. Overexpression of Fn14 promotes androgen independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis 2011; 32 (11): 1589-1596.
10. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M,. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 2007; 99 (23): 1793-1800.
11. Llaverias G, Danilo C, Wang Y, Witkiewicz AK, Daumer K, Lisanti MP, Frank PG,. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 2010; 177 (6): 3180-3191.
12. Venkateswaran V, Klotz LH,. Diet and prostate cancer: Mechanisms of action and implications for chemoprevention. Nat Rev Urol 2010; 7 (8): 442-453.
13. Gupta SC, Kim JH, Prasad S, Aggarwal BB,. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010; 29 (3): 405-434.
14. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256-269.
15. Singh RK, Sudhakar A, Lokeshwar BL,. Role of chemokines and chemokine receptors in prostate cancer development and progression. J Cancer Sci Ther 2010; 2 (4): 89-94.
16. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, Zhang J,. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 2006; 66 (12): 1311-1318.
17. Kobayashi N, Barnard RJ, Said J, Hong-Gonzalez J, Corman DM, Ku M, Doan NB, Gui D, Elashoff D, Cohen P, Aronson WJ,. Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Res 2008; 68 (8): 3066-3073.
18. Lu Y, Cai Z, Xiao G, Keller ET, Mizokami A, Yao Z, Roodman GD, Zhang J,. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 2007; 67 (8): 3646-3653.
19. Rozel S, Galban CJ, Nicolay K, Lee KC, Sud S, Neeley C, Snyder LA, Chenevert TL, Rehemtulla A, Ross BD, Pienta KJ,. Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem 2009; 107 (1): 58-64.
20. Kalaany NY, Sabatini DM,. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009; 458 (7239): 725-731.
21. Roca H, Varsos ZS, Mizutani K, Pienta KJ,. CCL2, survivin and autophagy: New links with implications in human cancer. Autophagy 2008; 4 (7): 969-971.
22. Pollard M, Luckert PH,. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986; 32 (2): 223-227.
23. Kondo Y, Homma Y, Aso Y, Kakizoe T,. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res 1994; 54 (23): 6129-6132.
24. Mavropoulos JC, Buschemeyer WC III, Tewari AK, Rokhfeld D, Pollak M, Zhao Y, Febbo PG, Cohen P, Hwang D, Devi G, Demark-Wahnefried W, Westman EC, Peterson BL, Pizzo SV, Freedland SJ,. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phila) 2009; 2 (6): 557-565.
25. Lloyd JC, Antonelli JA, Phillips TE, Masko EM, Thomas JA, Poulton SH, Pollak M, Freedland SJ,. Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol 2010; 183 (4): 1619-1624.
26. Ngo TH, Barnard RJ, Anton T, Tran C, Elashoff D, Heber D, Freedland SJ, Aronson WJ,. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res 2004; 64 (4): 1252-1254.
27. Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ, Cohen P, Hwang D, Peterson B, Fields T, Pizzo SV, Isaacs WB,. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 2008; 68 (1): 11-19.
28. Park R, Chang CC, Liang YC, Chung Y, Henry RA, Lin E, Mold DE, Huang RC,. Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors. Clin Cancer Res 2005; 11 (12): 4601-4609.
29. Yu H, Rohan T,. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92 (18): 1472-1489.
30. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM,. Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis. Int J Cancer 2009; 124 (10): 2416-2429.
31. Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD, Strieter RM,. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999; 154 (5): 1503-1512.
32. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK,. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62 (6): 1832-1837.
33. Reiland J, Furcht LT, McCarthy JB,. CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 1999; 41 (2): 78-88.
34. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP,. Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate 2010; 70 (5): 473-481.
35. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J,. CCR2 expression correlates with prostate cancer progression. J Cell Biochem 2007; 101 (3): 676-685.
36. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr., CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006; 116 (1): 115-124.
37. Aronson WJ, Barnard RJ, Freedland SJ, Henning S, Elashoff D, Jardack PM, Cohen P, Heber D, Kobayashi N,. Growth inhibitory effect of low fat diet on prostate cancer cells: Results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol 2010; 183 (1): 345-350.
38. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD,. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995; 87 (19): 1456-1462.